19 studies found for:    Open Studies | "Pyelonephritis"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Pyelonephritis" (19 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Antibiotic Prophylaxis in Children With Pyelonephritis
Condition: Pyelonephritis
Interventions: Drug: Trimethoprim Sulfamethoxazole;   Drug: placebo
2 Recruiting Effect of Acetylcysteine in Pediatric Acute Pyelonephritis.
Condition: Pyelonephritis
Interventions: Drug: Acetylcysteine;   Drug: placebo acetylcysteine
3 Recruiting Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis
Conditions: Urinary Tract Infections;   Acute Pyelonephritis
Interventions: Drug: Finafloxacin 800 mg i.v. once daily;   Drug: Finafloxacin placebo i.v. once daily;   Drug: Finafloxacin 800 mg tablets (as four 200 mg tablets) once daily;   Drug: Finafloxacin placebo tablets (as four tablets) once daily;   Drug: Ciprofloxacin 400 mg i.v. two times daily;   Drug: Ciprofloxacin placebo i.v. two times daily;   Drug: Ciprofloxacin 500 mg oral (as two 250 mg capsules) two times daily;   Drug: Ciprofloxacin placebo oral (as two capsules each) two times daily
4 Recruiting Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Uncomplicated Pyelonephritis Due to Extended-spectrum β-lactamase Producing Escherichia Coli
Condition: Uncomplicated Pyelonephritis Due to ESBL-producing E.Coli
Intervention: Drug: Cefoxitin
5 Not yet recruiting Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis
Condition: Pyelonephritis
Intervention: Other: No intervention
6 Recruiting L-carnitine on the Prevention of Renal Scarring in Acute Pyelonephritis
Condition: Acute Pyelonephritis(APN)
Intervention: Drug: L-carnitine
7 Recruiting Compare Ceftazidime-Avibactam and Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
Conditions: cUTI;   Complicated Urinary Tract Infection;   Acute Pyelonephritis
Interventions: Drug: CAZ-AVI;   Drug: Doripenem;   Drug: Either switch to oral therapy : 500 mg of Ciprofloxacin (oral);   Drug: or switch to oral therapy : 800 mg/160 mg of sulfamethoxazole/trimethoprim
8 Recruiting Oral Omega-3 for Reduction of Kidney Scar Due to Pyelonephritis in Children
Condition: Acute Pyelonephritis(APN)
Intervention: Drug: Omega-3
9 Recruiting Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
Condition: Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis
Interventions: Drug: CAZ-AVI;   Drug: Doripenem;   Drug: Either switch to oral therapy: 500 mg of Ciprofloxacin (oral);   Drug: or switch to oral therapy: 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)
10 Recruiting Dexamethasone Administration in 1st Episode of Febrile Urinary Tract Infection
Condition: Acute Pyelonephritis
Intervention:
11 Not yet recruiting Antibiotic Treatment Versus no Therapy in Kidney Transplant Recipients With Asymptomatic Bacteriuria
Conditions: Asymptomatic Bacteriuria;   Pyelonephritis
Interventions: Drug: Antibiotic treatment;   Other: No treatment
12 Recruiting Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
Conditions: Urinary Tract Infections;   Pyelonephritis
Interventions: Drug: MK-7655 250 mg;   Drug: MK-7655 125 mg;   Drug: imipenem/cilastatin 500 mg;   Drug: Placebo to MK-7655
13 Recruiting Cranberry-lingonberry Juice Started During Acute Infection in Prevention of Urinary Tract Infections in Children
Conditions: Urinary Tract Infection;   Pyelonephritis;   Cystitis
Intervention: Other: Cranberry-lingonberry juice
14 Unknown  Contrast-Enhanced US of Spleen, Liver and Kidney
Conditions: Malaria;   Pyelonephritis;   Bacterial Infections
Intervention:
15 Not yet recruiting Efficacy, Safety, Tolerability of Carbavance Compared to Best Available Therapy in Serious Infections Due to Carbapenem Resistant Enterobacteriaceae, in Adults
Conditions: Urinary Tract Infection Complicated;   Acute Pyelonephritis;   Hospital Acquired Bacterial Pneumonia;   Ventilator-associated Bacterial Pneumonia;   Bacteremia
Interventions: Drug: Carbavance;   Drug: Best Available Therapy
16 Not yet recruiting Efficacy, Safety, Tolerability of Carbavance Compared to Piperacillin/Tazobactam in cUTIs, Including AP, in Adults
Conditions: Urinary Tract Infection Complicated;   Acute Pyelonephritis
Interventions: Drug: Carbavance;   Drug: Piperacillin/tazobactam;   Drug: Levofloxacin oral
17 Not yet recruiting Bacterial and Host Genetic Risk Factors in Acute Pyelonephritis
Condition: Vesicoureteral Reflux
Intervention:
18 Unknown  Urinary Cytokine Levels as a Prognostic Marker for Kidney Scarring After Pyelonephritis
Condition: Kidney Scarring Post-Febrile UTI
Intervention:
19 Unknown  Febrile Urinary Tract Infection Randomized Short Treatment Trial
Condition: Urinary Tract Infection
Intervention: Drug: short treatment (ciprofloxacin)

Indicates status has not been verified in more than two years